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USE OF EXPLANTED HUMAN 
HEARTS AS A MODEL FOR 
THE STUDY OF CARDIAC 
PATHOPHYSIOLOGIC 
CONDITIONS 
The purpose of this paper is to describe an isolated heart model that uses 
human hearts to study cardiomyopathy. Techniques of organ preparation 
and perfusion are described that result in successful restoration of 
explanted human hearts to a beating condition. Native hearts of transplant 
recipients were placed on an isolated perfusion circuit immediately after 
explant. After appropriate organ and circuit preparation these hearts were 
restored to a functional state. Studies were done to assess the stability over 
time and response to inotropic stimulation. Six of seven hearts were 
returned to a functional condition. Left ventricular pressure generation 
ranged from 56 to 118 mm Hg (mean 84.8 - 34.11) at physiologic loading 
conditions. Hearts remained functional from 67 to 271 minutes (mean 
152 - 71.7) and retained up to 70% of functional capacity after 120 
minutes. Hearts performed in isovolumic and ejecting modes. Hearts had a 
marked response to inotrope administration not previously described. We 
conclude that human hearts can be reproducibly restored to a functional 
condition after explant from transplant recipients and can be maintained 
in a beating state with reasonably stable pressure generation for an 
extended period of time, which makes this a useful model with which to 
study cardiac pathophysiologic conditions. These hearts demonstrate an 
appropriate response to inotropes not previously observed, most likely 
because of improved myocardial preservation and stringent control of 
perfusate chemical make-up. (J THORAC CARDIOVASC SURG 1995;110: 
239-47) 
James P. Slater, MD, Evan C. Lipsitz, MD, Jonathen M. Chen, MD, 
Howard R. Levin, MD, Mehmet C. Oz, MD, and Daniel Burkhoff, MD,'PhD, 
New York, N.Y. 
I n 1895 Langendorff ~ first described the use of an isolated heart preparation as a model with which 
to study myocellular and myocardial function. With 
the use of animal hearts this model has yielded 
information that has become the cornerstone to 
understanding cardiac physiologic processes. 2' 3 A 
shortcoming common to all of these studies is the 
necessity of using animal-derived data to extrapolate 
to the human condition. This problem is com- 
pounded by the need to induce or otherwise xper- 
imentally create the heart failure condition in stud- 
ies of pathophysiologic conditions. 
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In 1988 Burkhoff and co-workers 4 recognized 
these limitations and reported a new Langendorff 
model that made use of cardiac transplant recipi- 
ents' native hearts. These hearts were restored to a 
beating condition by being placed on a cardiopul- 
monary bypass circuit immediately after explanta- 
tion. This was the first reported use of the Langen- 
dorff model in which the mechanics of human hearts 
were studied. 5 Although not completely representa- 
tive of the in vivo state, data from this model 
complement previous efforts to describe human 
cardiomyopathy. There are several limitations, how- 
ever, with the model  As noted by the authors, 4 this 
preparation requires a mandatory period of isch- 
emia, which may diminish cardiac function. No 
information is obtained from the hearts in vivo, 
which makes comparison between the in vivo and ex 
vivo states difficult. Finally, no  comparison data 
from normal hearts are available. Several other 
limitations are apparent. Most notably, the perfused 
hearts beat for only a brief time and exhibited stable 
cardiac function over an even shorter period. In 
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addition, no response to inotropic challenge was 
observed. Beyond listing the initial constituents of 
the perfusate no assessment of blood chemistry 
components was made throughout he experiment. 
Last, a univentricular rather than biventricular 
model was used. 
The purpose of this paper is to describe an 
improved, biventricular, isolated human heart 
model for the study of cardiomyopathy. We present 
techniques of organ preparation and describe per- 
fusion techniques that result in successful return of 
human hearts to a beating condition after explant. 
We assess the stability of cardiac function over time 
and test the responsiveness of the heart to inotropic 
drug administration. 
Methods 
Clinical evaluation. All patients were participants in 
the cardiac transplant program at the Columbia-Presby- 
terian Medical Center and underwent standard evaluation 
before acceptance, including detailed demographic pro- 
file; echocardiography or gated blood pool scan, or both; 
and cardiac atheterization. Catheterization data from the 
right side of the heart were obtained from a Swan-Ganz 
catheter (Baxter Healthcare Corp., Edwards Division, 
Santa Ana, Calif.) placed at the time of transplantation. 
All information presented was obtained for clinical use. 
No additional information was obtained for this study. 
This study was done with the approval of our Institu- 
tional Review Board. 
Isolated heart preparation 
Organ procurement and preparation. Patients were 
brought o operation for the purpose of orthotopic ardiac 
transplantation. Patients were anesthetized, and cardio- 
pulmonary bypass was established in standard fashion. 
Hearts were arrested with 10 ml/kg of 4:1 blood:crystalloid 
(KC1 120 rag/L, mannitol 12.5 gm/L, HCO 3 mEq/L) 
cardioplegia solution administered through an aortic can- 
nula after application of the aortic crossclamp. Hearts 
were explanted leaving the majority of atrial tissue and 
ascending aorta in situ. The hearts were cooled to 4 ~ C by 
immediate immersion in an iced saline bath in the oper- 
ating room to minimize warm ischemic time. All subse- 
quent preparation was done with the heart in this bath. 
A modification of techniques previously described was 
used to prepare the hearts. 4 In the initial five hearts 
chordae tendineae were left intact: In the last two hearts 
all chordae to valve leaflets were severed. Oblong-shaped 
brass rings were sutured to the mitral and triscupid anuli. 
Once positioned these rings blocked both the left and 
right ventricular (LV and RV) outflow tracts. These rings 
were fitted with cuffs containing set screws that positioned 
the heart on a volume servo system (discussed later). 
DeBakey coronary perfusion cannulas (C. R. Bard Inc., 
Tewksbury, Mass.) in 14F and 12F sizes were inserted into 
right ,and left coronary ostia, respectively. A Gundry 
RCSP catheter (DLP, Grand Rapids, Mich.) was inserted 
into the coronary sinus and the balloon inflated. The 
heart was then transported to the laboratory in the water 
bath. 
Perfusion system. The perfusion circuit was an open 
system similar to that previously described and illustrated 
in Fig. 1. 4 The system consisted of a COBE CML Ultra 
membrane oxygenator with a cardiotomy reservoir con- 
taining a 30/xm filter (COBE, Arvada, Colo.), a circulat- 
ing water bath, a hollow fiber dialysis tubing cartridge 
(COBE), a roller head pump (Sarns, Ann Arbor, Mich.), 
an in-line pH and temperature meter (Cardiovascular 
Devices, Inc., Ann Arbor, Mich.), and 1/4- and 3/16-inch 
connective tubing. Total circuit volume was 600 ml. 
Coronary venous blood drained spontaneously through 
the coronary sinus catheter and thebesian flow drained 
through stab wounds in the right and left ventricle; all 
drainage was collected in a large funnel and directed to 
the cardiotomy reservoir where it was warmed by an 
internal heating element via the water bath. The blood 
was then drawn from the reservoir by the roller head 
pump and passed through the dialysis cartridge on its 
return to the membrane oxygenator. This oxygenated 
blood was pumped to the cannulas in the coronary arteries 
or coronary sinus. 
The system was primed with 750 ml Dianeal low 
calcium (2.5 mg/L) peritoneal dialysis solution with 1.5% 
dextrose (Baxter, Deerfield, Ill.) and debubbled. To the 
prime was added two units of recently outdated, type- 
specific, noncrossmatched packed red blood cells. The red 
blood cells were washed to remove excess potassium and 
citrate by mixing with 250 ml normal saline solution and 
centrifuging at 4400 rpm for 5 minutes followed by 
decanting. Two hundred units of heparin and 300 mg of 
calcium gluconate were added to each unit of packed cells. 
An additional 1000 units of heparin was added to the 
circuit. The prime was recirculated through the system 
against a heated water bath and the perfusate allowed to 
come to 37 ~ C. 
Before the heart was reperfused corrective measures 
were required to adjust potassium concentration, pH, and 
calcium concentration of the perfusate to make the solu- 
tion physiologic. The perfusate was dialyzed against he 
same dialysis fluid used in the prime supplemented with 
600 mg of calcium gluconate. Initially no potassium was 
added to the system and the perfusate was dialyzed to a 
potassium concentration of less than 1.5 mEq/ml. Once 
this low potassium concentration Was achieved approxi- 
mately 2 mEq of potassium was added directly to the 
prime and an additional 2mEq/L of potassium was added 
to the dialysate. This resulted in a potassium concentra- 
tion of 3.5 to 4.5 mEq/L in the perfusate, which was 
maintained throughout the experiment. Initial pH mea- 
surements were acidotic (pH 6.5) because of the compo- 
sition of the dialysis fluid and stored blood. This was 
corrected and proper pH maintained by addition of 
approximately 50 mEq sodium bicarbonate directly to the 
perfusate. Similarly, calcium gluconate was added to the 
dialysate to maintain an ionized calcium level of approx- 
imately 0.9 mEq/L. Electrolyte and pH values were mon- 
itored throughout he experiment using a Nova Star 
Profile 5 (Nova Biomedical, Waltham, Mass.) and the 
in-line pH monitor (CDI). ACT determinations just be- 
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Fig. 1. Schematic drawing of isolated perfusion circuit and biventricular servo system. RCA, Right 
coronary artery; LCA, left coronary artery. 
fore reperfusion were higher than 200 seconds and re- 
mained at this level for the duration of the experiment. 
The perfusate was oxygenated through the membrane 
oxygenator with an admixture of compressed air and 
carbogen (95% oxygen, 5% carbon dioxide2). The sweep 
gas and percent carbogen were adjusted to maintain a 
carbon dioxide tension of 30 to 34 torr. The hemoglobin 
oxygen saturation was 100% throughout the experiment 
as determined by periodic determinations of blood gas 
values. 
The preparation described was done in the physiology 
laboratory before explant of the heart. When the heart 
was brought o the lab all parameters had been corrected 
and were within physiologic range. In this manner, the 
heart could be reperfused immediately on its arrival and 
ischemic time minimized. 
Servo system. After the surgical preparation was com- 
pleted , the heart was attached to RV and LV volume 
servo-control systems. Details of their design have been 
reported previously. 6'7 In brief, motor-driven piston 
pumps regulate he volume of a balloon placed within 
each ventricular chamber (see Fig. 1). The mitral and 
triscuspid rings serve to confine the balloon within the 
respective ventricular chamber. This system therefore 
provides the means to measure and control ventricular 
volume. In addition, a micromanometer sensor inside 
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Table I. Demographic and clinical characteristics of transplant recipients whose hearts were used in this study 
Age Height Weight ABO Previous Echo MUGA 
Patient Sex (yr) (cm) (kg) group Cardiornyopathy ype operative history (%) (%) 
1 M 39 180 106.7 A+ idiopathic None 25 18 
2 M 60 168 57.7 B+ Ischemic None - -  21 
3 M 51 180 95.3 A+ Ischemic CABG/LVAD 20 - -  
4 M 63 165 54.5 AB+ Ischemic CABG 9 - -  
5 F 56 160 45.4 B+ Ischemic None - -  13 
6 M 65 177 68 O+ Ischemic LV aneurysm repair - -  21 
7 M 62 183 102 A+ Ischemic None 25 42 
Echo, Ejection fraction by two-dimensional echocard~ography; MUGA, ejection fraction by multiple gated acquisition scan. 
Table I I .  Pretransplant and postinduction hemodynamic data from transplant recipients in this study 
Pretransplant Postinduction 
PVR HR 
PAS PAD PCWP CO CI (Wood (beats/ SBP DBP PAS PAD CO CI Ino- 
Patient (mrn Hg) (rnm Hg) (ram Hg) (L/min) (L/min.m 2) units) mira (ram Hg) tram Hg) (ram Hg) (mrn Hg) (L/min) (L/min.m e) tropes 
1 27 10 3 6.21 2.75 1.9313 80 120 75 31 18 6;1 DBA 
2 43 15 26 2.75 1.67- 3.8 80 100 60 20 3.6 2.3 DBA 
3 20 4 4 5.98 2.78 1.33 70 120 60 16 5.4 None 
4 38 18 19 2.17 1.36 3.68 60 110 60 65 30 DBA 
5 62 19 15 3.31 2.29 5.14 85 140 70 - -  None 
6 60 23 20 3.1 1.7 5.2 90 110 60 74 35 2.7 DBA 
7 74 14 38 3.28 4.26 60 200 100 25 3.77 DBA 
PAS. Pulmonary artery systolic pressure: PAD, pulmonary artery diastolic pressure: PCWP. pulmonary capillary wedge pressure; CO, cardiac output; CI, 
cardiac index: PVR. pulmonary vascular resistance; HR, heart rate: SBP, systolic blood pressure: DBP diastolic blood pressure: DBA. dobutamine. 
each balloon is used to measure intraventricular pressure, 
Both RV and LV volume servo systems are controlled 
by a computer that is programmed either to impose 
physiologic ejection and filling flow patterns or to con- 
strain the ventricles to contract isovolumetrically as re- 
quired by the protocol. Details of the design of this 
computer control system are similar to those described 
previously.8. 9 Briefly, a digital computer was programmed 
with the differential equations describing the entire cir- 
culatory system with parameter values that can be ad- 
justed from the computer keyboard. 9 The computer 
digitizes the instantaneous LV and RV .pressures and 
calculates the appropriate instantaneous flow in or out of 
each ventricle for the specified simulated vascular prop- 
erties. These flow signals are integrated and used as 
command signals for the RV and LV volume servo 
systems, respectively. The mode of contraction can be 
switched to isovolumic when desired, at which point 
there is independent control of the volume within each 
ventricle. 
Reperfusion. The heart was initially reperfused in ret- 
rograde fashion via the coronary sinus catheter to remove 
air from the coronary arteries. After a short time retro- 
grade perfusion was stopped, the coronary sinus balloon 
was deflated and opened to air, and antegrade flow was 
initiat'ed. Several hearts fibrillated initially on rewarming 
and }equired electric cardioversion with ventricular pac- 
ing: These hearts restarted after one 30-joule shock only. 
/ 
All hearts were paced via pacing wires inserted into the 
LV apex. Temperature was maintained between 35 ~ C and 
37 ~ C by use of a circulating water bath and was monitored 
by both epicardial surface probe and the in-line temper- 
ature monitor (CDI). 
Protocol The purpose of this experiment was to test the 
stability and responsiveness to inotropic stimulation of 
isolated myopathic human hearts and to demonstrate he 
potential usefulness of this model for the study of cardiac 
pathophysi01ogic conditions. To this end our experiments 
consisted of returning the hearts to a beating condition, 
showing acceptable pressure generation, demonstrating 
stability of function over time, and exhibiting an appro- 
priate response to inotropic drug administration. 
Results 
Seven human hearts were obtained from patients 
with end-stage congestive heart  fai lure at the t ime of 
cardiac transplantat ion.  Pat ient demographic  data 
(age, sex, weight, and height) are presented in Table 
I along with pert inent  transplant evaluation data 
including diagnosis, surgical history, and preopera-  
tive cardiac assessment. In addit ion, postinduction, 
intraoperat ive hemodynamic '  data taken at the t ime 
of t ransplantat ion are presented in Table II. 
Six of seven hearts were restored to a beating 
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Fig. 2. Mean function defined as developed LV pressure (systolic minus diastolic) over time for five of six 
revived hearts (heart No. 6 excluded, see text). Developed pressure at start of experiment is defined as 
100%. Pressure generation is stable over first 30 minutes; despite some decline, function is 70% of initial 
value at 120 minutes. 
condition. Thirty minutes after the heart was revived 
LV isovolumic systolic pressures ranged from 56 to 
118 mm Hg (mean 84.8 2 34.11). Corresponding 
diastolic pressure ranged from 30 to50  mm Hg 
(mean 40 2 5.15). Restored hearts functioned for 
periods ranging from 67 to 271 minutes with a mean 
of 152 _+ 71.7 minutes. One experiment (heart No. 
6) was abbreviated because of a water bath malfunc- 
tion that caused supraphysiologic temperatures that 
damaged the heart. Pressure data from this heart 
are excluded from analysis. The remaining hearts 
exhibited reasolaably stable pressure generation over 
a 2-hour period (Fig. 2). Representative r cordings 
for LV Pressure , LV volume, RV pressure, and RV 
volume during ejecting contractions are shown in 
Fig. 3. The computer-simulated arterial properties 
were set to provide a LV ejection fraction of 15% 
with a preload of 12 mm Hg. These tracings dem- 
onstrate our ability to imposephysiologic loading 
conditions on these isolated hearts. 
The effects of inotropic agents on LV and RV 
performance are shown in Fig. 4. Both epinephrine 
and calcium administration had a profound effect on 
LV and RV pressure generation (panels 1 and 2). 
Effects of calcium were appropriately blunted by a 
calcium channel blocker (panel 3, left). Subsequent 
administration of calcium after calcium channel 
blockade again demonstrated a significant inotropic 
effect (panel 3, right). 
Perfusate blood chemistry values were monitored 
throughout each experiment. Oxygen tension, carbon 
dioxide tension, and oxygen saturation tended to re- 
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Fig. 3. Example of LV pressure (LVP) and volume (LW) and RV pressure (RVP) and volume (RW) 
during ejecting mode run. One block equals 10 mm Hg. 
main within normal ranges once properly ad- 
justed. Levels of pH, potassium, and ionized 
calcium required more diligent management. Fig. 
5 demonstrates the trends of pH, potassium, and 
ionized calcium levels. 
Discussion 
We demonstrate hat it is possible to reproducibly 
revive excised human hearts on a perfusion circuit 
for the purpose of studying cardiac pathophysiologic 
conditions. Although laboratory experimentation 
necessitates imposition of artificial conditions, we 
believe that this model will be useful in future 
studies of human heart physiologic and pathophys- 
iologic conditions. 
Despite the large number of reported studies on 
isolated animal heart preparations we believe our 
model and methods to offer certain advantages. 
With this model there is no need to extrapolate from 
data derived from animal models of heart failure. In 
contrast o results in a previous experience with this 
model we were able to  demonstrate prolonged, 
reasonably stable cardiac function in repeated trials. 
In addition, this preparation exhibited the appropri- 
ate response to pharmacologic challenges with both 
inotropes and myocardial depressants not previously 
shown. In comparison with the previous study of 
isolated human hearts these data indicate that the 
methods reported here result in more stable ventric- 
ular function, which may result from improved 
myocardial preservation. The ability to obtain data 
from both velitricles represents a technologic im- 
provement over the previously used univentricular 
model. 
We believe that the success of this model is 
dependent on two key elements: expedient prepara- 
tion of the organ and meticulous preparation and 
maintenance of the blood perfusate. The heart must 
be placed in a cold saline bath immediately on explant. 
Heart preparation and transPort must take place with 
the heart submerged to ensure that the heart is kept 
cold up until the time of reperfusion. This is required 
to minimize warm ischemic time. The perfusion circuit 
must be set up and primed well in advance of organ 
availability. In our experience the circuit and perfusate 
require approximately 2 hours to set up and prime. 
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Physiologic parameters are reached approximately tA
hour before organ arrival. Frequent electrolyte and 
blood gas value determinations are essential to make 
the necessary adjustments o the perfusate. A stable 
circulating water bath is also required to maintain 
physiologic onditions. 
Having established the feasibility of this model we 
believe that its use may provide an opportunity o
study specific aspects of myocardial disease not 
previously done in human beings. Ventricular inter- 
dependence has been shown to exist; however, the 
degree to which RV function is dependent on LV 
function for pressure generation in the diseased 
human heart is unknown, m The load-dependent 
nature of ventricular performance may also be more 
accurately quantified in the diseased human heart. 
This model may be used to compare different car- 
diac preservation solutions under varying delivery 
techniques. Properties Of myocardial metabolism 
are also easily studied in these hearts. 
Analysis of the experimental data presented re- 
veals isovolumic peak LV pressure generation be- 
tween 15 and 70 mm Hg without inotropic support. 
In an isovolumic model this represents a decrease in 
contractility compared with in situ conditions even 
for end-stage congestive heart failure. For example, 
previous studies that used normal dog hearts 
showed peak systolic pressures in excess of 155 mm 
Hg. aa Potential reasons for this relatively low pres- 
sure generation include ischemic insult during the 
period of nonperfusion, suboptimal perfusate com- 
position, and loss of inotropic support. No similar 
studies have been done on human hearts without 
heart failure and ata from normal control hearts 
might better place in perspective the performance of 
these diseased hearts. Potential sources for such 
organs might be patients who donate organs other 
than the heart in whom the heart has been jtjdged 
unsuitable for clinical use. 
Previous studies have suggested that disruption 
of the valvular apparatus results in impaired 
ventricular pressure generation, a2More recently 
other investigators have shown little effect on 
ventricular function after the chordae are sev- 
ered. a~ This experiment depends on accurate vol- 
ume measurement and assumes that the intraven- 
tricular balloon Will conform to the shape of the 
ventricular cavity. Intact anterior chordae tendi- 
neae act as a barrier to the balloon, preventing it
from coming to rest along the septal wall of the 
ventricle. To avoid this problem we have elected 
to sever the chordae tendineae. 
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Fig. 4. LV pressure (LVP) and RV pressure (RVP) dur- 
ing isovolumic run. Top panel, Before (Pre) and after 
(PosO 1 mg epinephrine injection to circuit. Middle panel, 
Before and after 1 gm calcium injection to circuit. Bottom 
panel, After verapamil injection (left) and after 1 gm calcium 
injection repeat (righO. One block equals 10 mm Hg. 
In conclusion, we have presented a unique model 
for the study of human cardiac pathophysiologic 
conditions. Explanted human hearts obtained at the 
time of cardiac transplant can be reproducibly re- 
stored to a functional condition on a perfusion 
circuit. The heart can be maintained in a beating 
state for an extended period. Pressure generation 
remains reasonably stable over this interval, which 
allows for accurate study of ventricular properties of 
the diseased heart. These hearts respond appropri- 
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Fig. 5. Changes in levels of pH, potassium, and ionized calcium during preparation (Pre), at the start of 
reperfusion (Start), and throughout the experiment (During). Eachpoint represents mean plus or minus 1 
standard eviation for all hearts at that time. 
ately to inotrope administration byincreasing pres- 
sure generation. The longer duration of viability and 
responsiveness to inotropic stimulation represent 
improvements over previously used techniques to 
study isolated hearts. These improvements are 
likely caused by better myocardial preservation 
and more stringent control of blood perfusate 
chemistry values. 
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